You just read:

3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

News provided by

3SBio Inc.

Nov 17, 2019, 19:30 ET